The influence of inhibitors of macromolecular syntheses on capacity of herpes simplex virus to induce chromosomal damage.
D002277:Carcinoma; D002460:Cell Line; D002869:Chromosome Aberrations; D003078:Colchicine; D003470:Culture Media; D046508:Culture Techniques; D003561:Cytarabine / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology*; D003851:Deoxyribonucleases / Q000378:metabolism; D005796:Genes; D005827:Genetics, Microbial; D006801:Humans; D007621:Karyotyping; D007739:L Cells; D007822:Laryngeal Neoplasms; D011691:Puromycin / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis; D018139:Simplexvirus / Q000187:drug effects / Q000378:metabolism / Q000472:pathogenicity*; D013223:Statistics as Topic; D013997:Time Factors
D003470:Culture Media; D004279:DNA, Viral; D012333:RNA, Messenger; D003561:Cytarabine; D003609:Dactinomycin; D011691:Puromycin; D003851:Deoxyribonucleases; D003078:Colchicine